Global CBD markets are under pressure after the European Commission (EC) asserted that CBD extracts from hemp flowers aren’t valid for approval under the Novel Foods policy. A spokesperson for the EC said primary concern lies with “CBD extracted from the flowering and fruiting tops of the hemp plant (Cannabis sativa)”. The European Commission has “informed the applicants of its preliminary views and invited them to provide comments”, the spokesperson added. This includes 50 applicants from a number of countries, including the US.
Czech based CBDepot submitted their application for synthetic CBD to the European Food Safety Authority (EFSA) in November of last year. On March 31, CBDepot’s application for registering synthesized trans-CBD as a ‘Novel Food’ substance appeared as EC Mandate# M-2018-0021 on EFSA’s Register of Questions portal:
…
12.20.2024
45z guidance fails to appear; government scrambles to pass spending bill
The US government spending bill failed twice in as many days. If a deal is not reached by midnight on Friday December 20, some federal services will...
12.20.2024
US animal fats and oils end week softer across the board ahead of holiday slowdown
Prices for US animal fats and oils ended the week on a lower note on Friday December 20, with most markets trending downward ahead of the upcoming holiday week,...
12.20.2024
December cattle on feed down on month, year
Most US animal protein prices were rangebound for the week, though in wider ranges due to the impending Christmas and New Year's holiday closures.
The only significant price...